Cargando…
Rational design of thioamide peptides as selective inhibitors of cysteine protease cathepsin L
Aberrant levels of cathepsin L (Cts L), a ubiquitously expressed endosomal cysteine protease, have been implicated in many diseases such as cancer and diabetes. Significantly, Cts L has been identified as a potential target for the treatment of COVID-19 due to its recently unveiled critical role in...
Autores principales: | Phan, Hoang Anh T., Giannakoulias, Sam G., Barrett, Taylor M., Liu, Chunxiao, Petersson, E. James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901119/ https://www.ncbi.nlm.nih.gov/pubmed/35355937 http://dx.doi.org/10.1039/d1sc00785h |
Ejemplares similares
-
Thioamide-Based
Fluorescent Protease Sensors
por: Goldberg, Jacob M., et al.
Publicado: (2014) -
Structural impact of thioamide incorporation into a β-hairpin
por: Fiore, Kristen E., et al.
Publicado: (2022) -
Cysteine Protease Cathepsins in Atherosclerotic Cardiovascular Diseases
por: Wu, Hongxian, et al.
Publicado: (2018) -
Odanacatib, a Cathepsin K Cysteine Protease Inhibitor, Kills Hookworm In Vivo
por: Vermeire, Jon J., et al.
Publicado: (2016) -
Apoferritin encapsulation of cysteine protease inhibitors for cathepsin L inhibition in cancer cells
por: Quilles Junior, José C., et al.
Publicado: (2019)